Jacobson J, Qiao J, Cochran E, McCreery S, Chung D
Front Oncol. 2024; 14:1336031.
PMID: 38884093
PMC: 11176429.
DOI: 10.3389/fonc.2024.1336031.
Zhao X, Xu Z, Feng X
BMC Pediatr. 2024; 24(1):162.
PMID: 38454422
PMC: 10921780.
DOI: 10.1186/s12887-024-04570-z.
He M, Cai J, Wu X, Tang Y, Wang J, Mao J
World J Pediatr. 2023; 20(3):250-258.
PMID: 38070095
PMC: 10957663.
DOI: 10.1007/s12519-023-00773-z.
Krystal J, Foster J
Children (Basel). 2023; 10(8).
PMID: 37628301
PMC: 10453838.
DOI: 10.3390/children10081302.
Avanzini S, DallIgna P, Bjornland K, Braungart S, Cross K, Flores P
Pediatr Surg Int. 2023; 39(1):191.
PMID: 37140693
DOI: 10.1007/s00383-023-05477-z.
Establishment and validation of a nomogram to predict cancer-specific survival in pediatric neuroblastoma patients.
Chen W, Lin P, Bai J, Fang Y, Zhang B
Front Pediatr. 2023; 11:1105922.
PMID: 36937951
PMC: 10020339.
DOI: 10.3389/fped.2023.1105922.
High-Risk Neuroblastoma: A Surgical Perspective.
Jacobson J, Clark R, Chung D
Children (Basel). 2023; 10(2).
PMID: 36832517
PMC: 9955866.
DOI: 10.3390/children10020388.
Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study.
Li Q, Wang J, Cheng Y, Hu A, Li D, Wang X
J Clin Med. 2023; 12(3).
PMID: 36769402
PMC: 9918249.
DOI: 10.3390/jcm12030754.
Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma.
Qiao J, Liu J, Jacobson J, Clark R, Lee S, Liu L
PLoS One. 2022; 17(12):e0277956.
PMID: 36525420
PMC: 9757561.
DOI: 10.1371/journal.pone.0277956.
Association of Image-Defined Risk Factors with Clinical, Biological Features and Outcome in Neuroblastoma.
Laura B, Radu B, Patricia C, Andreea M
Children (Basel). 2022; 9(11).
PMID: 36360435
PMC: 9688519.
DOI: 10.3390/children9111707.
Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine.
Mastrangelo S, Attina G, Zagaria L, Romano A, Ruggiero A
Cancers (Basel). 2022; 14(20).
PMID: 36291955
PMC: 9599979.
DOI: 10.3390/cancers14205170.
Combination bromo- and extraterminal domain and poly (ADP-ribose) polymerase inhibition synergistically enhances DNA damage and inhibits neuroblastoma tumorigenesis.
Jacobson J, Qiao J, Clark R, Chung D
Discov Oncol. 2022; 13(1):103.
PMID: 36227363
PMC: 9562984.
DOI: 10.1007/s12672-022-00563-5.
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment.
Bartolucci D, Montemurro L, Raieli S, Lampis S, Pession A, Hrelia P
Cancers (Basel). 2022; 14(18).
PMID: 36139583
PMC: 9496712.
DOI: 10.3390/cancers14184421.
Changes in image-defined risk factors with neoadjuvant chemotherapy in pediatric abdominal neuroblastoma.
Wang H, Chen X, Zhu J, Zhang K, Lu J, Zhang L
Abdom Radiol (NY). 2022; 47(10):3520-3530.
PMID: 35790567
DOI: 10.1007/s00261-022-03596-0.
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
Desai A, Applebaum M, Karrison T, Oppong A, Yuan C, Berg K
Cancer. 2022; 128(15):2967-2977.
PMID: 35665495
PMC: 10764281.
DOI: 10.1002/cncr.34263.
Upregulation of CD3ζ and L-selectin in antigen-specific cytotoxic T lymphocytes by eliminating myeloid-derived suppressor cells with doxorubicin to improve killing efficacy of neuroblastoma cells in vitro.
Xu W, Li S, Li M, Zhou H, Yang X
J Clin Lab Anal. 2021; 36(1):e24158.
PMID: 34861064
PMC: 8761462.
DOI: 10.1002/jcla.24158.
Surgical Approaches to Neuroblastoma: Review of the Operative Techniques.
Fati F, Pulvirenti R, Paraboschi I, Martucciello G
Children (Basel). 2021; 8(6).
PMID: 34070327
PMC: 8227756.
DOI: 10.3390/children8060446.
Molecular targeting therapies for neuroblastoma: Progress and challenges.
Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F
Med Res Rev. 2020; 41(2):961-1021.
PMID: 33155698
PMC: 7906923.
DOI: 10.1002/med.21750.
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
Barr E, Laurie K, Wroblewski K, Applebaum M, Cohn S
Pediatr Blood Cancer. 2020; 67(10):e28390.
PMID: 32710697
PMC: 7722196.
DOI: 10.1002/pbc.28390.